Showing results (141-150 of 291) with videos related to
Sort By:
Pageof 30
Journal of Hepatology|April 19, 2006
Prediction model of hepatocarcinogenesis for patients with hepatitis C virus-related cirrhosis. Validation with internal and external cohortsKenji Ikeda, Yasuji Arase, Satoshi Saitoh, et al.Hepatology (Baltimore, Md.)|December 6, 2012
Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infectionTetsuya Hosaka, Fumitaka Suzuki, Masahiro Kobayashi, et al.Digestive Diseases and Sciences|September 9, 2017
Direct-Acting Antivirals Decreased Tumor Recurrence After Initial Treatment of Hepatitis C Virus-Related Hepatocellular CarcinomaKenji Ikeda, Yusuke Kawamura, Masahiro Kobayashi, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 3, 2019
Long-term outcome of hepatocellular carcinoma occurrence, esophageal varices exacerbation, and mortality in hepatitis C virus-related liver cirrhosis after interferon-based therapyNobuhiko Ogasawara, Satoshi Saitoh, Norio Akuta, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 22, 2017
Predictors of pruritus in patients with chronic liver disease and usefulness of nalfurafine hydrochlorideNorio Akuta, Hiromitsu Kumada, Shunichiro Fujiyama, et al.Journal of Medical Virology|January 13, 2017
Ledipasvir plus sofosbuvir as salvage therapy for HCV genotype 1 failures to prior NS5A inhibitors regimensNorio Akuta, Hitomi Sezaki, Fumitaka Suzuki, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 9, 2014
Effectiveness and safety of reduced-dose telaprevir-based triple therapy in chronic hepatitis C patientsHitomi Sezaki, Fumitaka Suzuki, Tetsuya Hosaka, et al.Intervirology|October 6, 2012
Efficacy and anticarcinogenic activity of ribavirin combination therapy for hepatitis C virus-related compensated cirrhosisNorio Akuta, Fumitaka Suzuki, Yuya Seko, et al.Journal of Medical Virology|August 30, 2012
Association of IL28B genotype and viral response of hepatitis C virus genotype 2 to interferon plus ribavirin combination therapyNorio Akuta, Fumitaka Suzuki, Yuya Seko, et al.BMC Gastroenterology|November 20, 2021
PNPLA3 genotype and fibrosis-4 index predict cardiovascular diseases of Japanese patients with histopathologically-confirmed NAFLDNorio Akuta, Yusuke Kawamura, Yasuji Arase, et al.Pageof 30